Biomedical Engineering Reference
In-Depth Information
Nel, A., Xia, T., Madler, L., and N. Li. 2006. Toxic potential of materials at the nanolevel.
Science
311:622-7.
Nielsen, G.D., Roursgaard, M., Jensen, K.A., Poulsen, S.S., and S.T. Larsen. 2008.
In vivo
biology and toxicol-
ogy of fullerenes and their derivatives.
Basic Clin. Pharmacol. Toxicol.
103:197-208.
Norppa, H., Catalán, J., Falck, G., Hannukainen, K., Siivola, K., and K. Savolainen. 2011. Nano-specific geno-
toxic effects.
J. Biomed. Nanotechnol.
7:19.
Organisation for Economic Cooperation & Development (OECD). 1977. Test Guideline 471: Bacterial reverse
mutation test. In: OECD Guidelines for testing of chemicals.
Organisation for Economic Cooperation & Development (OECD). 1977. Test Guideline 473.
In vitro
mam-
malian chromosome aberration test. In: OECD Guidelines for testing of chemicals.
Organisation for Economic Cooperation & Development (OECD). 1997. Test Guideline 474. Mammalian
erythrocyte micronucleus. In: OECD Guidelines for testing of chemicals.
Organisation for Economic Cooperation & Development (OECD). 1997. Test Guideline 475. Mammalian bone
marrow chromosome aberration test. In: OECD Guidelines for testing of chemicals.
Organisation for Economic Cooperation & Development (OECD). 1997. Test Guideline 476.
In vitro
mam-
malian cell gene mutation test. In: OECD Guidelines for testing of chemicals.
Organisation for Economic Cooperation & Development (OECD). 2009. Preliminary Review of OECD Test
Guidelines for their Applicability to Manufactured Nanomaterials. Series of Safety of Manufactured
Nanomaterials No. 15.
Organisation for Economic Cooperation & Development (OECD). 2010. Test Guideline 487.
In vitro
mam-
malian cell micronucleus test. In: OECD Guidelines for testing of chemicals.
Organisation for Economic Cooperation & Development (OECD). OECD guidelines for the testing of chemi-
cals; http://www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-
health-effects_20745788.
Paino, I.M., Marangoni, V.S., de Oliveira R. de C., Antunes, L.M., and V. Zucolotto. 2012. Cyto and genotox-
icity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells.
Toxicol. Lett.
215:119-25.
Park, M.V., Neigh A.M., Vermeulen, J.P. et al. 2011a. The effect of particle size on the cytotoxicity, inflamma-
tion, developmental toxicity and genotoxicity of silver nanoparticles.
Biomaterials
32:9810-7.
Park, M.V., Verharen, H.W., Zwart, E. et al. 2011b. Genotoxicity evaluation of amorphous silica nanoparticles
of different sizes using the micronucleus and the plasmid lacZ gene mutation assay.
Nanotoxicology
5:168-81.
Petkovic, J., Zegura, B., Stevanovic, M. et al. 2011. DNA damage and alterations in expression of DNA dam-
age responsive genes induced by TiO
2
nanoparticles in human hepatoma HepG2 cells.
Nanotoxicology
5:341-53.
Pfaller, T., Colognato, R., Nelissen, I. et al. 2010. The suitability of different cellular
in vitro
immunotoxicity
and genotoxicity methods for the analysis of nanoparticle-induced events.
Nanotoxicology
4:52-72.
PubMed database: www.ncbi.nlm.nih.gov/pubmed/
Schins, R.P. 2002. Mechanisms of genotoxicity of particles and fibers.
Inhal. Toxicol.
14, 57-78.
Schins, R.P. and A.M. Knaapen. 2007. Genotoxicity of poorly soluble particles.
Inhal. Toxicol.
19:189-98.
Sergent, J.A., Paget, V., and S. Chevillard. 2012. Toxicity and genotoxicity of nano-SiO2 on human epithelial
intestinal HT-29 cell line.
Ann. Occup. Hyg.
56:622-30.
Shah, V., Taratula, O., Garbuzenco, O.B. et al. 2012. Genotoxicity of different nanocarriers: Possible modifica-
tions for the delivery of nucleic acids.
Curr. Drug Discov. Technol.
10:8-15.
Singh, N., Jenkins G.J., Nelson, B.C. et al. 2012. The role of iron redox state in the genotoxicity of ultrafine
superparamagnetic iron oxide nanoparticles.
Biomaterials
33:163-70.
Singh, N., Manshian, B., Jenkins, G.J. et al. 2009. Nanogenotoxicology: The DNA damaging potential of engi-
neered nanomaterials.
Biomaterials
30, 3891-914.
Singh, S. and H.S. Nalwa. 2007. Nanotechnology and health safety- toxicity and risk assessments of nanostruc-
tured materials on human health.
J. Nanosci. Nanotechnol.
7:3048-70.
Stella, G.M. 2011. Carbon nanotubes and pleural damage: Perspectives of nanosafety in the light of asbestos
experience.
Biointerphases
6:1-17.
Stone, V., Johnston, H., and R.P. Schins. 2009. Development of
in vitro
systems for nanotoxicology:
Methodological considerations.
Crit. Rev. Toxicol.
39:613-26.
Tang, M., Zhang, T., Xue, Y. et al. 2010. Dose dependent
in vivo
metabolic characteristics of titanium dioxide
nanoparticles.
J. Nanosci. Nanotechnol.
10:8575-83.
Tice, R.R., Agurell, E., Anderson, D. et al. 2000. Single cell gel/comet assay: Guidelines for
in vitro
and
in vivo
genetic toxicology testing.
Environ. Mol. Mutagen
. 35:206-21.
